Equus asinus breed Dezhou chromosome 23, ASM1607732v2, whole genome shotgun sequence.
Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; Eutheria; Laurasiatheria; Perissodactyla; Equidae; Equus.
Donkey genomes provide new insights into domestication and selection for coat color
REFSEQ INFORMATION: The reference sequence is identical to\nCM027712.2.\nAssembly name: ASM1607732v2\nThe genomic sequence for this RefSeq record is from the\nwhole-genome assembly released by the Dairy Cattle Research Center,\nShandong Academy of Agricultural Sciences on 2021/10/14. The\noriginal whole-genome shotgun project has the accession\nJADWZW000000000.2.\n\n##Genome-Assembly-Data-START##\nAssembly Provider :: Dairy Cattle Research Center, Shandong\n Academy of Agricultural Sciences\nAssembly Method :: SOAPdenovo v. 2.04.4; DBG2OLC v. 1;\n 3D-DNA v. 170123\nGenome Representation :: Full\nExpected Final Version :: Yes\nGenome Coverage :: 211.0x\nSequencing Technology :: Illumina HiSeq; PacBio Sequel; Hi-C\n##Genome-Assembly-Data-END##\n\n##Genome-Annotation-Data-START##\nAnnotation Provider :: NCBI\nAnnotation Status :: Full annotation\nAnnotation Name :: Equus asinus Annotation Release 101\nAnnotation Version :: 101\nAnnotation Pipeline :: NCBI eukaryotic genome annotation\n pipeline\nAnnotation Software Version :: 9.0\nAnnotation Method :: Best-placed RefSeq; Gnomon\nFeatures Annotated :: Gene; mRNA; CDS; ncRNA\n##Genome-Annotation-Data-END##
Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 95% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106842334, transcript variant X1
COORDINATES: polyA evidence [ECO:0006239]
uncharacterized LOC106842334, transcript variant X2
major facilitator superfamily domain containing 14B, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
major facilitator superfamily domain containing 14B, transcript variant X2
major facilitator superfamily domain containing 14B, transcript variant X1
hippocampus abundant transcript-like protein 1 isoform X1
hippocampus abundant transcript-like protein 1 isoform X2
hippocampus abundant transcript-like protein 1 isoform X3
zinc finger protein 484, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein 484, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 43 samples with support for all annotated introns
zinc finger protein 484, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: cmsearch.
COORDINATES: nucleotide motif:Rfam:12.0:RF01229
nucleolar protein 8, transcript variant X10
nucleolar protein 8, transcript variant X9
nucleolar protein 8, transcript variant X4
nucleolar protein 8, transcript variant X8
nucleolar protein 8, transcript variant X1
nucleolar protein 8, transcript variant X3
nucleolar protein 8, transcript variant X5
nucleolar protein 8, transcript variant X6
nucleolar protein 8, transcript variant X2
nucleolar protein 8, transcript variant X7
nucleolar protein 8, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
centromere protein P, transcript variant X1
centromere protein P, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
extracellular matrix protein 2, transcript variant X3
extracellular matrix protein 2, transcript variant X4
extracellular matrix protein 2, transcript variant X1
extracellular matrix protein 2 isoform X1
extracellular matrix protein 2 isoform X3
extracellular matrix protein 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
extracellular matrix protein 2 isoform X2
inositol-pentakisphosphate 2-kinase, transcript variant X2
inositol-pentakisphosphate 2-kinase, transcript variant X1
inositol-pentakisphosphate 2-kinase, transcript variant X3
inositol-pentakisphosphate 2-kinase isoform X2
inositol-pentakisphosphate 2-kinase isoform X3
inositol-pentakisphosphate 2-kinase isoform X1
inositol-pentakisphosphate 2-kinase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 69 samples with support for all annotated introns
uncharacterized LOC106846184, transcript variant X2
uncharacterized LOC106846184, transcript variant X5
uncharacterized LOC106846184, transcript variant X3
uncharacterized LOC106846184, transcript variant X1
uncharacterized LOC106846184, transcript variant X4
BICD cargo adaptor 2, transcript variant X2
BICD cargo adaptor 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 77 samples with support for all annotated introns
FYVE, RhoGEF and PH domain containing 3, transcript variant X3
FYVE, RhoGEF and PH domain containing 3, transcript variant X4
FYVE, RhoGEF and PH domain containing 3, transcript variant X1
FYVE, RhoGEF and PH domain containing 3, transcript variant X5
FYVE, RhoGEF and PH domain containing 3, transcript variant X2
FYVE, RhoGEF and PH domain-containing protein 3 isoform X1
FYVE, RhoGEF and PH domain-containing protein 3 isoform X2
sushi domain containing 3, transcript variant X3
sushi domain containing 3, transcript variant X2
sushi domain-containing protein 3 isoform X2
sushi domain-containing protein 3 isoform X3
sushi domain containing 3, transcript variant X4
sushi domain-containing protein 3 isoform X4
sushi domain containing 3, transcript variant X1
sushi domain-containing protein 3 isoform X1
caspase recruitment domain family member 19
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: caspase recruitment domain-containing protein 19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 73% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: serine/threonine-protein kinase WNK2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
family with sequence similarity 120A, transcript variant X2
family with sequence similarity 120A, transcript variant X1
constitutive coactivator of PPAR-gamma-like protein 1 isoform X1
constitutive coactivator of PPAR-gamma-like protein 1 isoform X2
family with sequence similarity 120A, transcript variant X3
constitutive coactivator of PPAR-gamma-like protein 1 isoform X3
family with sequence similarity 120A, transcript variant X4
constitutive coactivator of PPAR-gamma-like protein 1 isoform X4
family with sequence similarity 120A, transcript variant X5
constitutive coactivator of PPAR-gamma-like protein 1 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 99% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
PHD finger protein 2, transcript variant X1
PHD finger protein 2, transcript variant X2
PHD finger protein 2, transcript variant X3
lysine-specific demethylase PHF2 isoform X1
lysine-specific demethylase PHF2 isoform X2
uncharacterized LOC123280085, transcript variant X2
uncharacterized LOC123280085, transcript variant X1
uncharacterized LOC123280125, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC123280125, transcript variant X2
uncharacterized LOC123280125, transcript variant X1
protein tyrosine phosphatase domain containing 1, transcript variant X9
protein tyrosine phosphatase domain containing 1, transcript variant X7
protein tyrosine phosphatase domain containing 1, transcript variant X8
protein tyrosine phosphatase domain containing 1, transcript variant X14
protein tyrosine phosphatase domain containing 1, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
protein tyrosine phosphatase domain containing 1, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
protein tyrosine phosphatase domain containing 1, transcript variant X10
protein tyrosine phosphatase domain containing 1, transcript variant X11
protein tyrosine phosphatase domain containing 1, transcript variant X6
protein tyrosine phosphatase domain containing 1, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
protein tyrosine phosphatase domain containing 1, transcript variant X2
protein tyrosine phosphatase domain containing 1, transcript variant X3
protein tyrosine phosphatase domain containing 1, transcript variant X1
protein tyrosine phosphatase domain containing 1, transcript variant X5
protein tyrosine phosphatase domain-containing protein 1 isoform X1
protein tyrosine phosphatase domain-containing protein 1 isoform X2
protein tyrosine phosphatase domain-containing protein 1 isoform X3
protein tyrosine phosphatase domain-containing protein 1 isoform X5
protein tyrosine phosphatase domain-containing protein 1 isoform X6
protein tyrosine phosphatase domain-containing protein 1 isoform X7
protein tyrosine phosphatase domain-containing protein 1 isoform X4
protein tyrosine phosphatase domain containing 1, transcript variant X15
protein tyrosine phosphatase domain-containing protein 1 isoform X8
zinc finger protein 169, transcript variant X4
zinc finger protein 169, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 52% coverage of the annotated genomic feature by RNAseq alignments
zinc finger protein 169, transcript variant X2
zinc finger protein 169, transcript variant X1
zinc finger protein 169, transcript variant X6
zinc finger protein 169, transcript variant X3
zinc finger protein 169, transcript variant X7
zinc finger protein 169, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
LOW QUALITY PROTEIN: NUT family member 2F
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 98% coverage of the annotated genomic feature by RNAseq alignments
cyclin dependent kinase 20, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
cyclin dependent kinase 20, transcript variant X6
cyclin dependent kinase 20, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
cyclin dependent kinase 20, transcript variant X9
cyclin dependent kinase 20, transcript variant X8
cyclin dependent kinase 20, transcript variant X5
cyclin dependent kinase 20, transcript variant X13
cyclin dependent kinase 20, transcript variant X10
cyclin dependent kinase 20, transcript variant X14
cyclin dependent kinase 20, transcript variant X11
cyclin dependent kinase 20, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
uncharacterized LOC123280177, transcript variant X2
uncharacterized LOC123280177, transcript variant X1
nucleoredoxin like 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
nucleoredoxin like 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
LOW QUALITY PROTEIN: sphingosine 1-phosphate receptor 3
LOW QUALITY PROTEIN: SHC-transforming protein 3
CDC28 protein kinase regulatory subunit 2
cyclin-dependent kinases regulatory subunit 2
SECIS binding protein 2, transcript variant X1
SECIS binding protein 2, transcript variant X2
SECIS binding protein 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
selenocysteine insertion sequence-binding protein 2 isoform X1
selenocysteine insertion sequence-binding protein 2 isoform X2
selenocysteine insertion sequence-binding protein 2 isoform X3
growth arrest and DNA damage inducible gamma
growth arrest and DNA damage-inducible protein GADD45 gamma
uncharacterized LOC123280189, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280189, transcript variant X2
uncharacterized LOC123280189, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
uncharacterized LOC123280189, transcript variant X1
uncharacterized LOC123280137, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
uncharacterized LOC123280137, transcript variant X2
uncharacterized LOC123280137, transcript variant X3
uncharacterized LOC123280254, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123280254, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
DIRAS family GTPase 2, transcript variant X3
DIRAS family GTPase 2, transcript variant X4
DIRAS family GTPase 2, transcript variant X2
DIRAS family GTPase 2, transcript variant X5
DIRAS family GTPase 2, transcript variant X1
DIRAS family GTPase 2, transcript variant X6
spleen associated tyrosine kinase, transcript variant X1
spleen associated tyrosine kinase, transcript variant X3
spleen associated tyrosine kinase, transcript variant X2
spleen associated tyrosine kinase, transcript variant X4
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X3
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X2
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X1
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X5
methylglutaconyl-CoA hydratase, mitochondrial isoform X3
methylglutaconyl-CoA hydratase, mitochondrial isoform X2
methylglutaconyl-CoA hydratase, mitochondrial isoform X1
methylglutaconyl-CoA hydratase, mitochondrial isoform X5
AU RNA binding methylglutaconyl-CoA hydratase, transcript variant X4
methylglutaconyl-CoA hydratase, mitochondrial isoform X4
nuclear factor, interleukin 3 regulated, transcript variant X1
nuclear factor, interleukin 3 regulated, transcript variant X2
nuclear factor interleukin-3-regulated protein
receptor tyrosine kinase like orphan receptor 2, transcript variant X3
receptor tyrosine kinase like orphan receptor 2, transcript variant X4
receptor tyrosine kinase like orphan receptor 2, transcript variant X6
receptor tyrosine kinase like orphan receptor 2, transcript variant X2
receptor tyrosine kinase like orphan receptor 2, transcript variant X1
receptor tyrosine kinase like orphan receptor 2, transcript variant X5
tyrosine-protein kinase transmembrane receptor ROR2 isoform X4
tyrosine-protein kinase transmembrane receptor ROR2 isoform X3
tyrosine-protein kinase transmembrane receptor ROR2 isoform X6
tyrosine-protein kinase transmembrane receptor ROR2 isoform X2
tyrosine-protein kinase transmembrane receptor ROR2 isoform X1
tyrosine-protein kinase transmembrane receptor ROR2 isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
uncharacterized LOC123280205, transcript variant X3
uncharacterized LOC123280205, transcript variant X4
uncharacterized LOC123280205, transcript variant X2
uncharacterized LOC123280205, transcript variant X1
serine palmitoyltransferase long chain base subunit 1, transcript variant X1
serine palmitoyltransferase 1 isoform X1
serine palmitoyltransferase long chain base subunit 1, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments
serine palmitoyltransferase 1 isoform X3
serine palmitoyltransferase long chain base subunit 1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 45 samples with support for all annotated introns
serine palmitoyltransferase 1 isoform X2
serine/threonine-protein kinase MRCK alpha-like, transcript variant X1
serine/threonine-protein kinase MRCK alpha-like, transcript variant X2
serine/threonine-protein kinase MRCK alpha-like isoform X1
serine/threonine-protein kinase MRCK alpha-like isoform X2
protein FAM205A-like, transcript variant X2
protein FAM205A-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 28 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: putative protein FAM205B
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: protein FAM205A-like
protein FAM205A-like, transcript variant X4
protein FAM205A-like, transcript variant X5
protein FAM205A-like, transcript variant X6
protein FAM205A-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 42 samples with support for all annotated introns
uncharacterized LOC123280097, transcript variant X3
uncharacterized LOC123280097, transcript variant X2
uncharacterized LOC123280097, transcript variant X4
uncharacterized LOC123280097, transcript variant X1
uncharacterized protein LOC123280097 isoform X1
uncharacterized protein LOC123280097 isoform X2
galactose-1-phosphate uridylyltransferase, transcript variant X2
galactose-1-phosphate uridylyltransferase, transcript variant X3
galactose-1-phosphate uridylyltransferase, transcript variant X1
galactose-1-phosphate uridylyltransferase, transcript variant X5
galactose-1-phosphate uridylyltransferase, transcript variant X6
galactose-1-phosphate uridylyltransferase isoform X2
galactose-1-phosphate uridylyltransferase isoform X3
galactose-1-phosphate uridylyltransferase isoform X1
galactose-1-phosphate uridylyltransferase isoform X5
galactose-1-phosphate uridylyltransferase, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
galactose-1-phosphate uridylyltransferase isoform X4
galactose-1-phosphate uridylyltransferase, transcript variant X7
galactose-1-phosphate uridylyltransferase isoform X6
sigma non-opioid intracellular receptor 1
AT-rich interaction domain 3C, transcript variant X1
AT-rich interaction domain 3C, transcript variant X2
AT-rich interaction domain 3C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 97% coverage of the annotated genomic feature by RNAseq alignments
AT-rich interactive domain-containing protein 3C
ribonuclease P/MRP subunit p25 like, transcript variant X2
ribonuclease P/MRP subunit p25 like, transcript variant X1
ribonuclease P/MRP subunit p25 like, transcript variant X4
ribonuclease P/MRP subunit p25 like, transcript variant X3
ribonuclease P protein subunit p25-like protein
ciliary neurotrophic factor receptor, transcript variant X4
ciliary neurotrophic factor receptor, transcript variant X2
ciliary neurotrophic factor receptor, transcript variant X3
ciliary neurotrophic factor receptor, transcript variant X1
ciliary neurotrophic factor receptor subunit alpha isoform X2
ciliary neurotrophic factor receptor subunit alpha isoform X1
energy homeostasis associated, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 79 samples with support for all annotated introns
energy homeostasis associated, transcript variant X2
family with sequence similarity 219 member A, transcript variant X4
family with sequence similarity 219 member A, transcript variant X2
family with sequence similarity 219 member A, transcript variant X3
family with sequence similarity 219 member A, transcript variant X9
family with sequence similarity 219 member A, transcript variant X1
family with sequence similarity 219 member A, transcript variant X6
family with sequence similarity 219 member A, transcript variant X8
family with sequence similarity 219 member A, transcript variant X7
family with sequence similarity 219 member A, transcript variant X5
chromosome 23 C9orf24 homolog, transcript variant X1
chromosome 23 C9orf24 homolog, transcript variant X3
chromosome 23 C9orf24 homolog, transcript variant X2
spermatid-specific manchette-related protein 1 isoform X1
spermatid-specific manchette-related protein 1 isoform X2
spermatid-specific manchette-related protein 1 isoform X3
chromosome 23 C9orf24 homolog, transcript variant X4
spermatid-specific manchette-related protein 1 isoform X4
myogenesis regulating glycosidase (putative), transcript variant X3
myogenesis regulating glycosidase (putative), transcript variant X2
myogenesis regulating glycosidase (putative), transcript variant X4
myogenesis regulating glycosidase (putative), transcript variant X5
myogenesis regulating glycosidase (putative), transcript variant X1
bis(5'-nucleosyl)-tetraphosphatase [asymmetrical]
kinesin family member 24, transcript variant X1
kinesin family member 24, transcript variant X2
kinesin family member 24, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
ubiquitin associated protein 1, transcript variant X3
ubiquitin associated protein 1, transcript variant X1
ubiquitin associated protein 1, transcript variant X2
ubiquitin-associated protein 1 isoform X1
ubiquitin-associated protein 1 isoform X2
DDB1 and CUL4 associated factor 12, transcript variant X2
DDB1- and CUL4-associated factor 12 isoform X2
DDB1 and CUL4 associated factor 12, transcript variant X1
DDB1 and CUL4 associated factor 12, transcript variant X3
DDB1- and CUL4-associated factor 12 isoform X3
DDB1- and CUL4-associated factor 12 isoform X1
ubiquitin associated protein 2, transcript variant X6
ubiquitin associated protein 2, transcript variant X7
ubiquitin associated protein 2, transcript variant X3
ubiquitin associated protein 2, transcript variant X1
ubiquitin associated protein 2, transcript variant X4
ubiquitin associated protein 2, transcript variant X5
ubiquitin associated protein 2, transcript variant X8
ubiquitin associated protein 2, transcript variant X2
ubiquitin-associated protein 2 isoform X1
ubiquitin-associated protein 2 isoform X3
ubiquitin-associated protein 2 isoform X5
ubiquitin-associated protein 2 isoform X6
ubiquitin-associated protein 2 isoform X2
ubiquitin-associated protein 2 isoform X4
ubiquitin-associated protein 2 isoform X7
COORDINATES: nucleotide motif:Rfam:12.0:RF01191
ubiquitin conjugating enzyme E2 R2, transcript variant X1
ubiquitin conjugating enzyme E2 R2, transcript variant X2
ubiquitin conjugating enzyme E2 R2, transcript variant X3
ubiquitin-conjugating enzyme E2 R2 isoform X1
ubiquitin-conjugating enzyme E2 R2 isoform X2
ubiquitin-conjugating enzyme E2 R2 isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 12 Proteins, and 64% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280302, transcript variant X2
uncharacterized LOC123280302, transcript variant X1
nuclear transcription factor, X-box binding 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; deleted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: transcriptional repressor NF-X1
BAG family molecular chaperone regulator 1
COORDINATES: nucleotide motif:Rfam:12.0:RF00026
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 51% coverage of the annotated genomic feature by RNAseq alignments
SMU1 DNA replication regulator and spliceosomal factor, transcript variant X1
SMU1 DNA replication regulator and spliceosomal factor, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 67 samples with support for all annotated introns
WD40 repeat-containing protein SMU1 isoform X1
WD40 repeat-containing protein SMU1 isoform X2
DnaJ heat shock protein family (Hsp40) member A1, transcript variant X1
DnaJ heat shock protein family (Hsp40) member A1, transcript variant X2
uncharacterized LOC123280120, transcript variant X1
uncharacterized LOC123280120, transcript variant X2
uncharacterized LOC123280251, transcript variant X1
uncharacterized LOC123280251, transcript variant X2
NADH:ubiquinone oxidoreductase subunit B6
NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 6
small integral membrane protein 27, transcript variant X2
small integral membrane protein 27, transcript variant X1
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase, transcript variant X1
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase, transcript variant X2
E3 ubiquitin-protein ligase Topors isoform X1
E3 ubiquitin-protein ligase Topors isoform X2
TOP1 binding arginine/serine rich protein, E3 ubiquitin ligase, transcript variant X3
DExD/H-box helicase 58, transcript variant X3
E3 ubiquitin-protein ligase Topors isoform X3
DExD/H-box helicase 58, transcript variant X1
DExD/H-box helicase 58, transcript variant X2
antiviral innate immune response receptor RIG-I isoform X1
antiviral innate immune response receptor RIG-I isoform X2
antiviral innate immune response receptor RIG-I isoform X3
cytoplasmic aconitate hydratase isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 40 samples with support for all annotated introns
cytoplasmic aconitate hydratase isoform X2
uncharacterized LOC123280256, transcript variant X3
uncharacterized LOC123280256, transcript variant X4
uncharacterized LOC123280256, transcript variant X6
uncharacterized LOC123280256, transcript variant X1
uncharacterized LOC123280256, transcript variant X2
uncharacterized LOC123280256, transcript variant X5
uncharacterized LOC123280248, transcript variant X4
uncharacterized LOC123280248, transcript variant X1
uncharacterized LOC123280248, transcript variant X3
uncharacterized LOC123280248, transcript variant X2
uncharacterized LOC106841455, transcript variant X2
uncharacterized LOC106841455, transcript variant X4
uncharacterized LOC106841455, transcript variant X5
uncharacterized LOC106841455, transcript variant X1
uncharacterized LOC106841455, transcript variant X3
uncharacterized LOC123280217, transcript variant X3
uncharacterized LOC123280217, transcript variant X1
uncharacterized LOC123280217, transcript variant X2
uncharacterized LOC123280209, transcript variant X8
uncharacterized LOC123280209, transcript variant X6
uncharacterized LOC123280209, transcript variant X4
uncharacterized LOC123280209, transcript variant X5
uncharacterized LOC123280209, transcript variant X11
uncharacterized LOC123280209, transcript variant X9
uncharacterized LOC123280209, transcript variant X12
uncharacterized LOC123280209, transcript variant X13
uncharacterized LOC123280209, transcript variant X7
uncharacterized LOC123280209, transcript variant X2
uncharacterized LOC123280209, transcript variant X1
uncharacterized LOC123280209, transcript variant X14
uncharacterized LOC123280209, transcript variant X10
uncharacterized LOC123280209, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280210, transcript variant X2
uncharacterized LOC123280210, transcript variant X3
uncharacterized LOC123280210, transcript variant X1
uncharacterized LOC123280266, transcript variant X3
uncharacterized LOC123280266, transcript variant X2
uncharacterized LOC123280266, transcript variant X1
uncharacterized LOC106836601, transcript variant X1
uncharacterized LOC106836601, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins
leucine rich repeat and Ig domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
leucine rich repeat and Ig domain containing 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
leucine rich repeat and Ig domain containing 2, transcript variant X7
leucine rich repeat and Ig domain containing 2, transcript variant X8
leucine rich repeat and Ig domain containing 2, transcript variant X11
leucine rich repeat and Ig domain containing 2, transcript variant X10
leucine rich repeat and Ig domain containing 2, transcript variant X6
leucine rich repeat and Ig domain containing 2, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins
uncharacterized LOC123280201, transcript variant X1
uncharacterized LOC123280201, transcript variant X2
leucine-rich repeat and immunoglobulin-like domain-containing nogo receptor-interacting protein 2
uncharacterized LOC123280124, transcript variant X1
uncharacterized LOC123280124, transcript variant X2
uncharacterized LOC106838954, transcript variant X3
uncharacterized LOC106838954, transcript variant X2
uncharacterized LOC106838954, transcript variant X1
C9orf72-SMCR8 complex subunit, transcript variant X3
C9orf72-SMCR8 complex subunit, transcript variant X1
C9orf72-SMCR8 complex subunit, transcript variant X2
C9orf72-SMCR8 complex subunit, transcript variant X4
guanine nucleotide exchange C9orf72 homolog
MOB kinase activator 3B, transcript variant X1
MOB kinase activator 3B, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC106838969, transcript variant X1
uncharacterized LOC106838969, transcript variant X2
RNA exonuclease 1 homolog, transcript variant X2
RNA exonuclease 1 homolog, transcript variant X1
TEK receptor tyrosine kinase, transcript variant X1
TEK receptor tyrosine kinase, transcript variant X2
intraflagellar transport 74, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 39 samples with support for all annotated introns
intraflagellar transport protein 74 homolog isoform X2
intraflagellar transport 74, transcript variant X5
intraflagellar transport 74, transcript variant X3
intraflagellar transport 74, transcript variant X4
intraflagellar transport 74, transcript variant X2
intraflagellar transport 74, transcript variant X1
intraflagellar transport protein 74 homolog isoform X1
intraflagellar transport 74, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
intraflagellar transport 74, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
intraflagellar transport 74, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
intraflagellar transport protein 74 homolog isoform X3
leucine-rich repeat-containing protein 19
caspase activity and apoptosis inhibitor 1
uncharacterized LOC123280173, transcript variant X2
uncharacterized LOC123280173, transcript variant X1
uncharacterized LOC123280175, transcript variant X2
uncharacterized LOC123280175, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 99% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: tumor suppressor candidate gene 1 protein
uncharacterized LOC123280230, transcript variant X2
uncharacterized LOC123280230, transcript variant X1
IZUMO family member 3, transcript variant X3
izumo sperm-egg fusion protein 3 isoform X3
IZUMO family member 3, transcript variant X1
IZUMO family member 3, transcript variant X2
izumo sperm-egg fusion protein 3 isoform X1
izumo sperm-egg fusion protein 3 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins
uncharacterized LOC123280142, transcript variant X3
uncharacterized LOC123280142, transcript variant X2
uncharacterized LOC123280142, transcript variant X4
uncharacterized LOC123280142, transcript variant X1
uncharacterized LOC123280142, transcript variant X5
ELAV like RNA binding protein 2, transcript variant X4
ELAV like RNA binding protein 2, transcript variant X6
ELAV like RNA binding protein 2, transcript variant X1
ELAV like RNA binding protein 2, transcript variant X3
ELAV like RNA binding protein 2, transcript variant X2
ELAV like RNA binding protein 2, transcript variant X5
ELAV like RNA binding protein 2, transcript variant X7
uncharacterized LOC123280227, transcript variant X3
uncharacterized LOC123280227, transcript variant X2
uncharacterized LOC123280227, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 4 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 31 samples with support for all annotated introns
LOW QUALITY PROTEIN: doublesex- and mab-3-related transcription factor A1
uncharacterized LOC106824774, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC106824774, transcript variant X11
uncharacterized LOC106824774, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC106824774, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC106824774, transcript variant X2
uncharacterized LOC106824774, transcript variant X3
uncharacterized LOC106824774, transcript variant X5
uncharacterized LOC106824774, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC106824774, transcript variant X6
uncharacterized LOC106824774, transcript variant X1
uncharacterized LOC106824774, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 49 samples with support for all annotated introns
uncharacterized LOC106824774, transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
uncharacterized LOC106824774, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
cyclin dependent kinase inhibitor 2B, transcript variant X2
cyclin dependent kinase inhibitor 2B, transcript variant X3
cyclin dependent kinase inhibitor 2B, transcript variant X1
uncharacterized LOC106824774, transcript variant X7
cyclin-dependent kinase inhibitor 2A-like, transcript variant X3
cyclin-dependent kinase inhibitor 2A-like, transcript variant X4
cyclin-dependent kinase inhibitor 2A-like, transcript variant X2
cyclin-dependent kinase inhibitor 2A-like, transcript variant X5
cyclin-dependent kinase inhibitor 2A-like, transcript variant X1
cyclin-dependent kinase 4 inhibitor B-like isoform X1
cyclin-dependent kinase inhibitor 2A-like isoform X2
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X1
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X4
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X6
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X3
S-methyl-5'-thioadenosine phosphorylase-like isoform X3
S-methyl-5'-thioadenosine phosphorylase-like isoform X5
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X2
S-methyl-5'-thioadenosine phosphorylase-like, transcript variant X5
S-methyl-5'-thioadenosine phosphorylase-like isoform X2
S-methyl-5'-thioadenosine phosphorylase-like isoform X4
S-methyl-5'-thioadenosine phosphorylase-like isoform X1
uncharacterized LOC106824713, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC106824713, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 77% coverage of the annotated genomic feature by RNAseq alignments
S-methyl-5'-thioadenosine phosphorylase, transcript variant X2
S-methyl-5'-thioadenosine phosphorylase, transcript variant X3
S-methyl-5'-thioadenosine phosphorylase, transcript variant X1
S-methyl-5'-thioadenosine phosphorylase isoform X3
S-methyl-5'-thioadenosine phosphorylase isoform X2
S-methyl-5'-thioadenosine phosphorylase isoform X1
uncharacterized LOC123280196, transcript variant X2
uncharacterized LOC123280196, transcript variant X1
uncharacterized LOC123280196, transcript variant X3
uncharacterized LOC123280196, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 94% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280116, transcript variant X1
uncharacterized LOC123280116, transcript variant X2
interferon epsilon, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns
interferon epsilon, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 30 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins, and 35% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 31 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 32 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 42% coverage of the annotated genomic feature by RNAseq alignments
interferon alpha-2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 21 Proteins, and 56% coverage of the annotated genomic feature by RNAseq alignments
interferon alpha-2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 69% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 24 Proteins, and 17% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 32 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 62% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 32 Proteins, and 84% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 33 Proteins, and 29% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 60% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 38 Proteins
uncharacterized LOC106824709, transcript variant X2
uncharacterized LOC106824709, transcript variant X3
uncharacterized LOC106824709, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 28 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 57% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 75% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 31% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 17 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 18 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 73% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 9 Proteins, and 92% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 16 Proteins, and 94% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins, and 95% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 47% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: interferon omega-1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
very-long-chain (3R)-3-hydroxyacyl-CoA dehydratase 4
LOW QUALITY PROTEIN: dnaJ homolog subfamily A member 1-like
MLLT3 super elongation complex subunit, transcript variant X3
MLLT3 super elongation complex subunit, transcript variant X4
MLLT3 super elongation complex subunit, transcript variant X2
MLLT3 super elongation complex subunit, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 26% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280261, transcript variant X1
uncharacterized LOC123280261, transcript variant X3
uncharacterized LOC123280261, transcript variant X2
solute carrier family 24 member 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 24 member 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
solute carrier family 24 member 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
solute carrier family 24 member 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
solute carrier family 24 member 2, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
sodium/potassium/calcium exchanger 2 isoform X1
sodium/potassium/calcium exchanger 2 isoform X3
sodium/potassium/calcium exchanger 2 isoform X2
sodium/potassium/calcium exchanger 2 isoform X4
uncharacterized LOC123280150, transcript variant X2
uncharacterized LOC123280150, transcript variant X1
uncharacterized LOC123280151, transcript variant X2
uncharacterized LOC123280151, transcript variant X1
alkaline ceramidase 2, transcript variant X2
alkaline ceramidase 2, transcript variant X1
DENN domain containing 4C, transcript variant X4
DENN domain containing 4C, transcript variant X2
DENN domain containing 4C, transcript variant X1
DENN domain containing 4C, transcript variant X6
DENN domain-containing protein 4C isoform X2
DENN domain-containing protein 4C isoform X1
DENN domain-containing protein 4C isoform X4
DENN domain-containing protein 4C isoform X6
DENN domain containing 4C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 18 samples with support for all annotated introns
DENN domain-containing protein 4C isoform X3
DENN domain containing 4C, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 34 samples with support for all annotated introns
DENN domain-containing protein 4C isoform X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 72% coverage of the annotated genomic feature by RNAseq alignments
HAUS augmin like complex subunit 6, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
HAUS augmin like complex subunit 6, transcript variant X2
HAUS augmin like complex subunit 6, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 54 samples with support for all annotated introns
HAUS augmin-like complex subunit 6 isoform X1
HAUS augmin-like complex subunit 6 isoform X2
COORDINATES: nucleotide motif:Rfam:12.0:RF00286
SH3 domain containing GRB2 like 2, endophilin A1, transcript variant X1
SH3 domain containing GRB2 like 2, endophilin A1, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 25 Proteins
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 5 Proteins, and 82% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
zinc finger protein basonuclin-2 isoform X1
zinc finger protein basonuclin-2 isoform X2
zinc finger protein basonuclin-2 isoform X3
zinc finger protein basonuclin-2 isoform X4
zinc finger protein basonuclin-2 isoform X5
zinc finger protein basonuclin-2 isoform X6
zinc finger protein basonuclin-2 isoform X8
zinc finger protein basonuclin-2 isoform X11
zinc finger protein basonuclin-2 isoform X13
zinc finger protein basonuclin-2 isoform X12
zinc finger protein basonuclin-2 isoform X7
zinc finger protein basonuclin-2 isoform X9
zinc finger protein basonuclin-2 isoform X10
uncharacterized LOC123280235, transcript variant X8
uncharacterized LOC123280235, transcript variant X9
uncharacterized LOC123280235, transcript variant X5
uncharacterized LOC123280235, transcript variant X4
uncharacterized LOC123280235, transcript variant X7
uncharacterized LOC123280235, transcript variant X6
uncharacterized LOC123280235, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC123280235, transcript variant X2
uncharacterized LOC123280235, transcript variant X1
uncharacterized LOC123280165, transcript variant X4
uncharacterized LOC123280165, transcript variant X1
uncharacterized LOC123280165, transcript variant X5
uncharacterized LOC123280165, transcript variant X6
uncharacterized LOC123280165, transcript variant X7
uncharacterized LOC123280165, transcript variant X3
uncharacterized LOC123280165, transcript variant X2
uncharacterized LOC123280165, transcript variant X8
coiled-coil domain containing 171, transcript variant X1
coiled-coil domain containing 171, transcript variant X2
coiled-coil domain-containing protein 171 isoform X2
coiled-coil domain-containing protein 171 isoform X1
coiled-coil domain containing 171, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
coiled-coil domain-containing protein 171 isoform X3
PC4 and SFRS1 interacting protein 1, transcript variant X5
PC4 and SFRS1 interacting protein 1, transcript variant X2
PC4 and SFRS1 interacting protein 1, transcript variant X3
PC4 and SFRS1 interacting protein 1, transcript variant X1
PC4 and SFRS1 interacting protein 1, transcript variant X9
PC4 and SFRS1 interacting protein 1, transcript variant X7
PC4 and SFRS1 interacting protein 1, transcript variant X6
PC4 and SFRS1 interacting protein 1, transcript variant X8
PC4 and SFRS1 interacting protein 1, transcript variant X4
PC4 and SFRS1-interacting protein isoform X1
PC4 and SFRS1-interacting protein isoform X2
PC4 and SFRS1-interacting protein isoform X3
PC4 and SFRS1-interacting protein isoform X5
PC4 and SFRS1-interacting protein isoform X4
small nuclear RNA activating complex polypeptide 3, transcript variant X1
small nuclear RNA activating complex polypeptide 3, transcript variant X2
snRNA-activating protein complex subunit 3 isoform X2
snRNA-activating protein complex subunit 3 isoform X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 22 Proteins
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tetratricopeptide repeat protein 39B
FRAS1 related extracellular matrix 1, transcript variant X10
FRAS1 related extracellular matrix 1, transcript variant X11
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
FRAS1 related extracellular matrix 1, transcript variant X9
FRAS1 related extracellular matrix 1, transcript variant X3
FRAS1 related extracellular matrix 1, transcript variant X4
FRAS1 related extracellular matrix 1, transcript variant X5
FRAS1 related extracellular matrix 1, transcript variant X6
FRAS1 related extracellular matrix 1, transcript variant X2
FRAS1 related extracellular matrix 1, transcript variant X1
FRAS1-related extracellular matrix protein 1 isoform X1
FRAS1-related extracellular matrix protein 1 isoform X2
FRAS1-related extracellular matrix protein 1 isoform X3
FRAS1-related extracellular matrix protein 1 isoform X4
FRAS1-related extracellular matrix protein 1 isoform X5
FRAS1-related extracellular matrix protein 1 isoform X6
FRAS1-related extracellular matrix protein 1 isoform X8
FRAS1-related extracellular matrix protein 1 isoform X9
FRAS1 related extracellular matrix 1, transcript variant X7
FRAS1 related extracellular matrix 1, transcript variant X12
FRAS1 related extracellular matrix 1, transcript variant X8
FRAS1-related extracellular matrix protein 1 isoform X7
FRAS1-related extracellular matrix protein 1 isoform X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
zinc finger DHHC-type palmitoyltransferase 21, transcript variant X2
zinc finger DHHC-type palmitoyltransferase 21, transcript variant X1
zinc finger DHHC-type palmitoyltransferase 21, transcript variant X4
zinc finger DHHC-type palmitoyltransferase 21, transcript variant X3
translation initiation factor IF-2-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
transfer RNA histidin (anticodon GUG); Derived by automated computational analysis using gene prediction method: tRNAscan-SE.
translation initiation factor IF-2-like, transcript variant X1
translation initiation factor IF-2-like isoform X1
translation initiation factor IF-2-like, transcript variant X5
translation initiation factor IF-2-like, transcript variant X4
translation initiation factor IF-2-like, transcript variant X6
translation initiation factor IF-2-like isoform X3
translation initiation factor IF-2-like, transcript variant X3
translation initiation factor IF-2-like isoform X2
nuclear factor I B, transcript variant X1
nuclear factor I B, transcript variant X2
nuclear factor I B, transcript variant X3
nuclear factor I B, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 13 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 32 samples with support for all annotated introns
nuclear factor I B, transcript variant X5
nuclear factor I B, transcript variant X6
uncharacterized LOC123280193, transcript variant X2
uncharacterized LOC123280193, transcript variant X3
uncharacterized LOC123280193, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs
multiple PDZ domain crumbs cell polarity complex component, transcript variant X2
multiple PDZ domain crumbs cell polarity complex component, transcript variant X1
multiple PDZ domain crumbs cell polarity complex component, transcript variant X3
multiple PDZ domain crumbs cell polarity complex component, transcript variant X5
multiple PDZ domain crumbs cell polarity complex component, transcript variant X4
uncharacterized LOC123280220, transcript variant X1
uncharacterized LOC123280220, transcript variant X2
5,6-dihydroxyindole-2-carboxylic acid oxidase
uncharacterized LOC123280260, transcript variant X2
uncharacterized LOC123280260, transcript variant X4
uncharacterized LOC123280260, transcript variant X8
uncharacterized LOC123280260, transcript variant X1
uncharacterized LOC123280260, transcript variant X3
uncharacterized LOC123280260, transcript variant X7
uncharacterized LOC123280260, transcript variant X5
uncharacterized LOC123280260, transcript variant X6
COORDINATES: nucleotide motif:Rfam:12.0:RF00156
uncharacterized LOC123280224, transcript variant X1
uncharacterized LOC123280224, transcript variant X2
protein tyrosine phosphatase receptor type D, transcript variant X2
uncharacterized LOC123280300, transcript variant X2
uncharacterized LOC123280300, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 83% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC106837517, transcript variant X2
uncharacterized LOC106837517, transcript variant X1
protein tyrosine phosphatase receptor type D, transcript variant X1
receptor-type tyrosine-protein phosphatase delta isoform X1
receptor-type tyrosine-protein phosphatase delta isoform X2
uncharacterized LOC123280252, transcript variant X2
uncharacterized LOC123280252, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein
distal membrane arm assembly component 1, transcript variant X1
distal membrane arm assembly component 1, transcript variant X2
distal membrane-arm assembly complex protein 1 isoform X1
distal membrane-arm assembly complex protein 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 14% coverage of the annotated genomic feature by RNAseq alignments
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
LOW QUALITY PROTEIN: lysine-specific demethylase 4C
uncharacterized LOC106837523, transcript variant X1
uncharacterized LOC106837523, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 23 Proteins, and 89% coverage of the annotated genomic feature by RNAseq alignments
glycine dehydrogenase (decarboxylating), mitochondrial
ubiquitin like with PHD and ring finger domains 2, transcript variant X3
ubiquitin like with PHD and ring finger domains 2, transcript variant X2
ubiquitin like with PHD and ring finger domains 2, transcript variant X9
ubiquitin like with PHD and ring finger domains 2, transcript variant X8
ubiquitin like with PHD and ring finger domains 2, transcript variant X7
ubiquitin like with PHD and ring finger domains 2, transcript variant X6
ubiquitin like with PHD and ring finger domains 2, transcript variant X5
E3 ubiquitin-protein ligase UHRF2 isoform X2
E3 ubiquitin-protein ligase UHRF2 isoform X4
ubiquitin like with PHD and ring finger domains 2, transcript variant X1
ubiquitin like with PHD and ring finger domains 2, transcript variant X4
E3 ubiquitin-protein ligase UHRF2 isoform X3
E3 ubiquitin-protein ligase UHRF2 isoform X1
uncharacterized LOC106843614, transcript variant X3
uncharacterized LOC106843614, transcript variant X2
uncharacterized LOC106843614, transcript variant X1
uncharacterized LOC106843614, transcript variant X4
spermatogenesis-associated protein 31D1-like
KIAA2026 ortholog, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X10
KIAA2026 ortholog, transcript variant X11
KIAA2026 ortholog, transcript variant X13
KIAA2026 ortholog, transcript variant X14
KIAA2026 ortholog, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 33 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
KIAA2026 ortholog, transcript variant X1
KIAA2026 ortholog, transcript variant X2
uncharacterized protein KIAA2026 homolog isoform X4
uncharacterized protein KIAA2026 homolog isoform X3
uncharacterized protein KIAA2026 homolog isoform X1
uncharacterized protein KIAA2026 homolog isoform X2
melanoma antigen recognized by T-cells 1
endoplasmic reticulum metallopeptidase 1, transcript variant X1
endoplasmic reticulum metallopeptidase 1 isoform X1
endoplasmic reticulum metallopeptidase 1, transcript variant X2
endoplasmic reticulum metallopeptidase 1 isoform X2
uncharacterized LOC123280105, transcript variant X2
uncharacterized LOC123280105, transcript variant X1
RIC1 homolog, RAB6A GEF complex partner 1, transcript variant X4
RIC1 homolog, RAB6A GEF complex partner 1, transcript variant X3
RIC1 homolog, RAB6A GEF complex partner 1, transcript variant X5
RIC1 homolog, RAB6A GEF complex partner 1, transcript variant X2
RIC1 homolog, RAB6A GEF complex partner 1, transcript variant X1
guanine nucleotide exchange factor subunit RIC1 isoform X4
guanine nucleotide exchange factor subunit RIC1 isoform X3
guanine nucleotide exchange factor subunit RIC1 isoform X5
guanine nucleotide exchange factor subunit RIC1 isoform X2
guanine nucleotide exchange factor subunit RIC1 isoform X1
uncharacterized LOC106843628, transcript variant X2
uncharacterized LOC106843628, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 16 samples with support for all annotated introns
plasminogen receptor with a C-terminal lysine, transcript variant X1
plasminogen receptor with a C-terminal lysine, transcript variant X4
plasminogen receptor with a C-terminal lysine, transcript variant X2
plasminogen receptor with a C-terminal lysine, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 11% coverage of the annotated genomic feature by RNAseq alignments
RNA terminal phosphate cyclase like 1, transcript variant X1
RNA terminal phosphate cyclase like 1, transcript variant X4
RNA 3'-terminal phosphate cyclase-like protein isoform X1
RNA 3'-terminal phosphate cyclase-like protein isoform X3
RNA terminal phosphate cyclase like 1, transcript variant X3
RNA terminal phosphate cyclase like 1, transcript variant X2
RNA 3'-terminal phosphate cyclase-like protein isoform X2
adenylate kinase 3, transcript variant X3
adenylate kinase 3, transcript variant X4
adenylate kinase 3, transcript variant X2
adenylate kinase 3, transcript variant X1
GTP:AMP phosphotransferase AK3, mitochondrial
cell division cycle 37 like 1, transcript variant X1
cell division cycle 37 like 1, transcript variant X2
hsp90 co-chaperone Cdc37-like 1 isoform X2
hsp90 co-chaperone Cdc37-like 1 isoform X1
uncharacterized LOC123280155, transcript variant X1
uncharacterized LOC123280155, transcript variant X2
spermatogenesis associated 6 like, transcript variant X2
spermatogenesis associated 6 like, transcript variant X3
spermatogenesis associated 6-like protein isoform X2
spermatogenesis associated 6-like protein isoform X3
spermatogenesis associated 6 like, transcript variant X1
spermatogenesis associated 6-like protein isoform X1
solute carrier family 1 member 1, transcript variant X3
solute carrier family 1 member 1, transcript variant X2
solute carrier family 1 member 1, transcript variant X1
excitatory amino acid transporter 3 isoform X3
excitatory amino acid transporter 3 isoform X2
excitatory amino acid transporter 3 isoform X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
LOW QUALITY PROTEIN: elongation factor 2-like
uncharacterized LOC123280154, transcript variant X2
uncharacterized LOC123280154, transcript variant X1
GLIS family zinc finger 3, transcript variant X1
GLIS family zinc finger 3, transcript variant X2
uncharacterized LOC106822481, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 94% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
uncharacterized LOC106822481, transcript variant X1
regulatory factor X3, transcript variant X5
regulatory factor X3, transcript variant X4
regulatory factor X3, transcript variant X8
regulatory factor X3, transcript variant X3
regulatory factor X3, transcript variant X7
regulatory factor X3, transcript variant X1
regulatory factor X3, transcript variant X6
regulatory factor X3, transcript variant X2
regulatory factor X3, transcript variant X9
regulatory factor X3, transcript variant X10
histone-arginine methyltransferase CARM1-like, transcript variant X1
histone-arginine methyltransferase CARM1-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
histone-arginine methyltransferase CARM1-like isoform X1
histone-arginine methyltransferase CARM1-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 27 Proteins
uncharacterized LOC106834833, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
uncharacterized LOC106834833, transcript variant X1
pumilio RNA binding family member 3, transcript variant X1
pumilio RNA binding family member 3, transcript variant X2
potassium voltage-gated channel modifier subfamily V member 2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
potassium voltage-gated channel subfamily V member 2
very low density lipoprotein receptor, transcript variant X1
very low density lipoprotein receptor, transcript variant X2
very low-density lipoprotein receptor isoform X2
very low-density lipoprotein receptor isoform X1
uncharacterized LOC106834855, transcript variant X3
uncharacterized LOC106834855, transcript variant X2
uncharacterized LOC106834855, transcript variant X1
uncharacterized LOC106834855, transcript variant X4
uncharacterized LOC123280092, transcript variant X1
uncharacterized LOC123280092, transcript variant X2
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 2 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: probable global transcription activator SNF2L2
uncharacterized LOC123280283, transcript variant X1
uncharacterized LOC123280283, transcript variant X3
uncharacterized LOC123280283, transcript variant X2
doublesex and mab-3 related transcription factor 2, transcript variant X1
doublesex and mab-3 related transcription factor 2, transcript variant X2
doublesex- and mab-3-related transcription factor 2 isoform X1
doublesex- and mab-3-related transcription factor 2 isoform X2
doublesex and mab-3 related transcription factor 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
doublesex- and mab-3-related transcription factor 2 isoform X3
doublesex and mab-3 related transcription factor 3
doublesex- and mab-3-related transcription factor 3
doublesex and mab-3 related transcription factor 1, transcript variant X2
doublesex and mab-3 related transcription factor 1, transcript variant X1
doublesex- and mab-3-related transcription factor 1 isoform X2
doublesex- and mab-3-related transcription factor 1 isoform X1
uncharacterized LOC123280198, transcript variant X3
uncharacterized LOC123280198, transcript variant X2
uncharacterized LOC123280198, transcript variant X1
KN motif and ankyrin repeat domains 1, transcript variant X3
KN motif and ankyrin repeat domains 1, transcript variant X1
KN motif and ankyrin repeat domains 1, transcript variant X2
KN motif and ankyrin repeat domains 1, transcript variant X7
KN motif and ankyrin repeat domains 1, transcript variant X6
KN motif and ankyrin repeat domains 1, transcript variant X5
KN motif and ankyrin repeat domains 1, transcript variant X4
KN motif and ankyrin repeat domain-containing protein 1 isoform X2
KN motif and ankyrin repeat domain-containing protein 1 isoform X1
KN motif and ankyrin repeat domain-containing protein 1 isoform X4
KN motif and ankyrin repeat domain-containing protein 1 isoform X3
uncharacterized LOC106834842, transcript variant X4
uncharacterized LOC106834842, transcript variant X1
uncharacterized LOC106834842, transcript variant X6
uncharacterized LOC106834842, transcript variant X5
uncharacterized LOC106834842, transcript variant X2
uncharacterized LOC106834842, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 61% coverage of the annotated genomic feature by RNAseq alignments
dedicator of cytokinesis 8, transcript variant X1
dedicator of cytokinesis 8, transcript variant X2
dedicator of cytokinesis 8, transcript variant X3
dedicator of cytokinesis protein 8 isoform X1
dedicator of cytokinesis protein 8 isoform X2
dedicator of cytokinesis protein 8 isoform X3
COBW domain containing 3, transcript variant X2
COBW domain containing 3, transcript variant X1
COBW domain containing 3, transcript variant X3
COBW domain-containing protein 3 isoform X1
COBW domain-containing protein 3 isoform X3
COBW domain-containing protein 3 isoform X2
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 4 bases in 3 codons; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: forkhead box protein D4-like 3
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X4
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X7
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X2
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X3
PP2A Aalpha (PPP2R1A) and B55A (PPP2R2A) interacting phosphatase regulator 1
PPP2R1A-PPP2R2A-interacting phosphatase regulator 1
phosphatidylinositol 4-phosphate 5-kinase type-1 beta isoform X2
phosphatidylinositol 4-phosphate 5-kinase type-1 beta isoform X5
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X6
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X5
phosphatidylinositol-4-phosphate 5-kinase type 1 beta, transcript variant X1
phosphatidylinositol 4-phosphate 5-kinase type-1 beta isoform X3
phosphatidylinositol 4-phosphate 5-kinase type-1 beta isoform X1
phosphatidylinositol 4-phosphate 5-kinase type-1 beta isoform X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 20% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280138, transcript variant X1
uncharacterized LOC123280138, transcript variant X3
uncharacterized LOC123280138, transcript variant X2
tight junction protein 2, transcript variant X4
tight junction protein 2, transcript variant X3
tight junction protein 2, transcript variant X2
tight junction protein 2, transcript variant X6
tight junction protein 2, transcript variant X8
tight junction protein 2, transcript variant X7
tight junction protein 2, transcript variant X5
tight junction protein 2, transcript variant X1
family with sequence similarity 189 member A2
amyloid beta precursor protein binding family A member 1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: deleted 3 bases in 2 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: amyloid-beta A4 precursor protein-binding family A member 1
protein prenyltransferase alpha subunit repeat containing 1
protein prenyltransferase alpha subunit repeat-containing protein 1
cilia and flagella associated protein 95, transcript variant X2
cilia and flagella associated protein 95, transcript variant X1
cilia and flagella associated protein 95, transcript variant X3
MAM domain containing 2, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
MAM domain containing 2, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
MAM domain containing 2, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
MAM domain containing 2, transcript variant X1
MAM domain containing 2, transcript variant X2
MAM domain-containing protein 2 isoform X1
MAM domain-containing protein 2 isoform X2
MAM domain-containing protein 2 isoform X3
MAM domain-containing protein 2 isoform X4
structural maintenance of chromosomes 5, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 17 samples with support for all annotated introns
structural maintenance of chromosomes 5, transcript variant X1
structural maintenance of chromosomes 5, transcript variant X2
structural maintenance of chromosomes 5, transcript variant X6
structural maintenance of chromosomes 5, transcript variant X4
structural maintenance of chromosomes 5, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
structural maintenance of chromosomes protein 5 isoform X1
structural maintenance of chromosomes protein 5 isoform X2
structural maintenance of chromosomes protein 5 isoform X5
structural maintenance of chromosomes protein 5 isoform X4
structural maintenance of chromosomes protein 5 isoform X3
uncharacterized LOC106834388, transcript variant X2
uncharacterized LOC106834388, transcript variant X1
uncharacterized LOC106834388, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
uncharacterized LOC123280126, transcript variant X3
transient receptor potential cation channel subfamily M member 3, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 6 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 15 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 3, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 11 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 10 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 mRNAs, 6 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 3, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 5 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments
transient receptor potential cation channel subfamily M member 3 isoform X9
transient receptor potential cation channel subfamily M member 3 isoform X3
transient receptor potential cation channel subfamily M member 3 isoform X7
transient receptor potential cation channel subfamily M member 3 isoform X1
transient receptor potential cation channel subfamily M member 3 isoform X4
transient receptor potential cation channel subfamily M member 3 isoform X8
transient receptor potential cation channel subfamily M member 3 isoform X2
transient receptor potential cation channel subfamily M member 3 isoform X6
uncharacterized LOC123280126, transcript variant X2
uncharacterized LOC123280126, transcript variant X1
transient receptor potential cation channel subfamily M member 3, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
transient receptor potential cation channel subfamily M member 3 isoform X5
cell migration inducing hyaluronidase 2, transcript variant X2
cell migration inducing hyaluronidase 2, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 6 Proteins, and 33% coverage of the annotated genomic feature by RNAseq alignments
abhydrolase domain containing 17B, depalmitoylase, transcript variant X6
abhydrolase domain containing 17B, depalmitoylase, transcript variant X3
abhydrolase domain containing 17B, depalmitoylase, transcript variant X5
abhydrolase domain containing 17B, depalmitoylase, transcript variant X2
abhydrolase domain containing 17B, depalmitoylase, transcript variant X4
abhydrolase domain containing 17B, depalmitoylase, transcript variant X1
alpha/beta hydrolase domain-containing protein 17B isoform X1
alpha/beta hydrolase domain-containing protein 17B isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 5 samples with support for all annotated introns
uncharacterized LOC123280178, transcript variant X1
uncharacterized LOC123280178, transcript variant X2
uncharacterized LOC106836140, transcript variant X2
uncharacterized LOC106836140, transcript variant X1
chromosome 23 C9orf57 homolog, transcript variant X1
chromosome 23 C9orf57 homolog, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 36 samples with support for all annotated introns
spermatogenesis-associated protein 31D4-like
ras and EF-hand domain-containing protein
FERM domain containing 3, transcript variant X2
FERM domain-containing protein 3 isoform X2
FERM domain containing 3, transcript variant X1
FERM domain-containing protein 3 isoform X1
uncharacterized LOC106824075, transcript variant X13
uncharacterized LOC106824075, transcript variant X15
uncharacterized LOC106824075, transcript variant X10
uncharacterized LOC106824075, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
uncharacterized LOC106824075, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
uncharacterized LOC106824075, transcript variant X12
uncharacterized LOC106824075, transcript variant X14
uncharacterized LOC106824075, transcript variant X2
uncharacterized LOC106824075, transcript variant X3
uncharacterized LOC106824075, transcript variant X5
uncharacterized LOC106824075, transcript variant X16
uncharacterized LOC106824075, transcript variant X1
uncharacterized LOC106824075, transcript variant X9
uncharacterized LOC106824075, transcript variant X7
uncharacterized LOC106824075, transcript variant X11
uncharacterized LOC106824075, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 53% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 96% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280145, transcript variant X1
uncharacterized LOC123280145, transcript variant X2
uncharacterized LOC106828620, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 27 samples with support for all annotated introns
uncharacterized LOC106828620, transcript variant X22
uncharacterized LOC106828620, transcript variant X23
uncharacterized LOC106828620, transcript variant X3
uncharacterized LOC106828620, transcript variant X16
uncharacterized LOC106828620, transcript variant X5
uncharacterized LOC106828620, transcript variant X28
uncharacterized LOC106828620, transcript variant X29
uncharacterized LOC106828620, transcript variant X18
uncharacterized LOC106828620, transcript variant X24
uncharacterized LOC106828620, transcript variant X25
uncharacterized LOC106828620, transcript variant X15
uncharacterized LOC106828620, transcript variant X30
uncharacterized LOC106828620, transcript variant X10
uncharacterized LOC106828620, transcript variant X26
uncharacterized LOC106828620, transcript variant X4
uncharacterized LOC106828620, transcript variant X2
uncharacterized LOC106828620, transcript variant X27
uncharacterized LOC106828620, transcript variant X8
uncharacterized LOC106828620, transcript variant X11
uncharacterized LOC106828620, transcript variant X17
uncharacterized LOC106828620, transcript variant X7
uncharacterized LOC106828620, transcript variant X14
uncharacterized LOC106828620, transcript variant X12
uncharacterized LOC106828620, transcript variant X20
uncharacterized LOC106828620, transcript variant X13
uncharacterized LOC106828620, transcript variant X6
uncharacterized LOC106828620, transcript variant X19
uncharacterized LOC106828620, transcript variant X21
uncharacterized LOC106828620, transcript variant X1
uncharacterized LOC106828620, transcript variant X31
uncharacterized LOC123280270, transcript variant X1
uncharacterized LOC123280270, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 91% coverage of the annotated genomic feature by RNAseq alignments
uncharacterized LOC123280186, transcript variant X2
uncharacterized LOC123280186, transcript variant X1
solute carrier family 28 member 3-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
solute carrier family 28 member 3-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, 10 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC106832890, transcript variant X2
uncharacterized LOC106832890, transcript variant X3
uncharacterized LOC106832890, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 EST, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 13 samples with support for all annotated introns
uncharacterized LOC106832890, transcript variant X1
uncharacterized LOC106832890, transcript variant X7
uncharacterized LOC106832890, transcript variant X5
uncharacterized LOC106832890, transcript variant X6
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 2 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: spermatogenesis-associated protein 31D1-like
uncharacterized LOC106828078, transcript variant X2
uncharacterized LOC106828078, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
uncharacterized LOC106828078, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
uncharacterized LOC106828078, transcript variant X1
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; substituted 1 base at 1 genomic stop codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: tumor protein D55-like
IDNK gluconokinase, transcript variant X4
IDNK gluconokinase, transcript variant X9
IDNK gluconokinase, transcript variant X3
IDNK gluconokinase, transcript variant X2
IDNK gluconokinase, transcript variant X1
IDNK gluconokinase, transcript variant X5
IDNK gluconokinase, transcript variant X10
IDNK gluconokinase, transcript variant X7
IDNK gluconokinase, transcript variant X6
IDNK gluconokinase, transcript variant X8
IDNK gluconokinase, transcript variant X11
IDNK gluconokinase, transcript variant X12
IDNK gluconokinase, transcript variant X14
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 71 samples with support for all annotated introns
IDNK gluconokinase, transcript variant X13
G kinase anchoring protein 1, transcript variant X3
G kinase anchoring protein 1, transcript variant X1
G kinase anchoring protein 1, transcript variant X2
uncharacterized LOC106823063, transcript variant X5
uncharacterized LOC106823063, transcript variant X6
uncharacterized LOC106823063, transcript variant X4
uncharacterized LOC106823063, transcript variant X3
uncharacterized LOC106823063, transcript variant X1
uncharacterized LOC106823063, transcript variant X2
kinesin family member 27, transcript variant X3
kinesin family member 27, transcript variant X4
kinesin family member 27, transcript variant X1
kinesin family member 27, transcript variant X2
kinesin family member 27, transcript variant X5
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 4 Proteins
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 6 bases in 4 codons; deleted 1 base in 1 codon; substituted 4 bases at 4 genomic stop codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: phosphoserine aminotransferase
heterogeneous nuclear ribonucleoprotein K, transcript variant X8
heterogeneous nuclear ribonucleoprotein K, transcript variant X7
heterogeneous nuclear ribonucleoprotein K, transcript variant X6
heterogeneous nuclear ribonucleoprotein K, transcript variant X2
heterogeneous nuclear ribonucleoprotein K, transcript variant X1
heterogeneous nuclear ribonucleoprotein K, transcript variant X3
heterogeneous nuclear ribonucleoprotein K, transcript variant X5
heterogeneous nuclear ribonucleoprotein K, transcript variant X4
heterogeneous nuclear ribonucleoprotein K isoform X4
heterogeneous nuclear ribonucleoprotein K isoform X2
heterogeneous nuclear ribonucleoprotein K isoform X3
heterogeneous nuclear ribonucleoprotein K isoform X1
RecQ mediated genome instability 1, transcript variant X3
RecQ mediated genome instability 1, transcript variant X5
RecQ mediated genome instability 1, transcript variant X4
recQ-mediated genome instability protein 1 isoform X2
RecQ mediated genome instability 1, transcript variant X2
RecQ mediated genome instability 1, transcript variant X7
RecQ mediated genome instability 1, transcript variant X8
RecQ mediated genome instability 1, transcript variant X9
RecQ mediated genome instability 1, transcript variant X6
RecQ mediated genome instability 1, transcript variant X10
RecQ mediated genome instability 1, transcript variant X11
RecQ mediated genome instability 1, transcript variant X1
recQ-mediated genome instability protein 1 isoform X1
solute carrier family 28 member 3-like, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 24 samples with support for all annotated introns
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: deleted 1 base in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins, and 93% coverage of the annotated genomic feature by RNAseq alignments
LOW QUALITY PROTEIN: solute carrier family 28 member 3-like
solute carrier family 28 member 3-like isoform X2
solute carrier family 28 member 3-like isoform X1
solute carrier family 28 member 3-like isoform X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 12 Proteins, and 99% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 12 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123280110, transcript variant X3
uncharacterized LOC123280110, transcript variant X1
uncharacterized LOC123280110, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 85% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 8 Proteins, and 27% coverage of the annotated genomic feature by RNAseq alignments
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 26% coverage of the annotated genomic feature by RNAseq alignments
solute carrier family 28 member 3, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 Proteins
solute carrier family 28 member 3 isoform X1
solute carrier family 28 member 3, transcript variant X2
solute carrier family 28 member 3 isoform X2
uncharacterized LOC106822023, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
uncharacterized LOC106822023, transcript variant X6
uncharacterized LOC106822023, transcript variant X3
uncharacterized LOC106822023, transcript variant X8
uncharacterized LOC106822023, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
uncharacterized LOC106822023, transcript variant X9
uncharacterized LOC106822023, transcript variant X10
uncharacterized LOC106822023, transcript variant X7
uncharacterized LOC106822023, transcript variant X2
uncharacterized LOC106822023, transcript variant X1
uncharacterized LOC106822023, transcript variant X11
uncharacterized LOC106822023, transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
neurotrophic receptor tyrosine kinase 2, transcript variant X2
neurotrophic receptor tyrosine kinase 2, transcript variant X4
neurotrophic receptor tyrosine kinase 2, transcript variant X11
neurotrophic receptor tyrosine kinase 2, transcript variant X12
neurotrophic receptor tyrosine kinase 2, transcript variant X5
neurotrophic receptor tyrosine kinase 2, transcript variant X7
neurotrophic receptor tyrosine kinase 2, transcript variant X1
neurotrophic receptor tyrosine kinase 2, transcript variant X3
neurotrophic receptor tyrosine kinase 2, transcript variant X6
neurotrophic receptor tyrosine kinase 2, transcript variant X8
neurotrophic receptor tyrosine kinase 2, transcript variant X9
neurotrophic receptor tyrosine kinase 2, transcript variant X10
BDNF/NT-3 growth factors receptor isoform X1
BDNF/NT-3 growth factors receptor isoform X3
BDNF/NT-3 growth factors receptor isoform X2
BDNF/NT-3 growth factors receptor isoform X4
BDNF/NT-3 growth factors receptor isoform X5
BDNF/NT-3 growth factors receptor isoform X6
BDNF/NT-3 growth factors receptor isoform X8
BDNF/NT-3 growth factors receptor isoform X7
ATP/GTP binding carboxypeptidase 1, transcript variant X1
ATP/GTP binding carboxypeptidase 1, transcript variant X6
ATP/GTP binding carboxypeptidase 1, transcript variant X3
ATP/GTP binding carboxypeptidase 1, transcript variant X5
ATP/GTP binding carboxypeptidase 1, transcript variant X4
ATP/GTP binding carboxypeptidase 1, transcript variant X2
ATP/GTP binding carboxypeptidase 1, transcript variant X8
ATP/GTP binding carboxypeptidase 1, transcript variant X9
ATP/GTP binding carboxypeptidase 1, transcript variant X7
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 1 sample with support for all annotated introns
uncharacterized LOC123280258, transcript variant X2
uncharacterized LOC123280258, transcript variant X3
uncharacterized LOC123280258, transcript variant X1
N-alpha-acetyltransferase 35, NatC auxiliary subunit
golgi membrane protein 1, transcript variant X2
golgi membrane protein 1, transcript variant X1
golgi membrane protein 1, transcript variant X3
chromosome 23 C9orf153 homolog, transcript variant X2
chromosome 23 C9orf153 homolog, transcript variant X9
chromosome 23 C9orf153 homolog, transcript variant X5
chromosome 23 C9orf153 homolog, transcript variant X10
chromosome 23 C9orf153 homolog, transcript variant X6
chromosome 23 C9orf153 homolog, transcript variant X4
chromosome 23 C9orf153 homolog, transcript variant X12
chromosome 23 C9orf153 homolog, transcript variant X8
chromosome 23 C9orf153 homolog, transcript variant X1
chromosome 23 C9orf153 homolog, transcript variant X11
chromosome 23 C9orf153 homolog, transcript variant X7
chromosome 23 C9orf153 homolog, transcript variant X3
uncharacterized protein C9orf153 homolog isoform X1
uncharacterized protein C9orf153 homolog isoform X3
uncharacterized protein C9orf153 homolog isoform X2
iron-sulfur cluster assembly 1, transcript variant X2
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X2
iron-sulfur cluster assembly 1, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 75 samples with support for all annotated introns
iron-sulfur cluster assembly 1 homolog, mitochondrial isoform X1
terminal uridylyl transferase 7, transcript variant X7
terminal uridylyl transferase 7, transcript variant X8
terminal uridylyl transferase 7, transcript variant X9
terminal uridylyl transferase 7, transcript variant X6
terminal uridylyltransferase 7 isoform X5
terminal uridylyltransferase 7 isoform X3
terminal uridylyltransferase 7 isoform X4
terminal uridylyltransferase 7 isoform X6
terminal uridylyl transferase 7, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 ESTs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
terminal uridylyl transferase 7, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 21 samples with support for all annotated introns
terminal uridylyl transferase 7, transcript variant X5
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
terminal uridylyl transferase 7, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 14 samples with support for all annotated introns
terminal uridylyl transferase 7, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 20 samples with support for all annotated introns
terminal uridylyl transferase 7, transcript variant X10
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 1 EST, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 10 samples with support for all annotated introns
terminal uridylyltransferase 7 isoform X1
terminal uridylyltransferase 7 isoform X2
terminal uridylyltransferase 7 isoform X7
uncharacterized LOC106822005, transcript variant X3
uncharacterized LOC106822005, transcript variant X1
uncharacterized LOC106822005, transcript variant X2
uncharacterized LOC123280247, transcript variant X4
uncharacterized LOC123280247, transcript variant X5
uncharacterized LOC123280247, transcript variant X2
uncharacterized LOC123280247, transcript variant X6
uncharacterized LOC123280247, transcript variant X3
uncharacterized LOC123280247, transcript variant X1
uncharacterized LOC123280280, transcript variant X1
uncharacterized LOC123280280, transcript variant X2
death associated protein kinase 1, transcript variant X4
death associated protein kinase 1, transcript variant X1
death associated protein kinase 1, transcript variant X7
death associated protein kinase 1, transcript variant X8
death associated protein kinase 1, transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 19 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 29 samples with support for all annotated introns
death associated protein kinase 1, transcript variant X3
death associated protein kinase 1, transcript variant X5
death associated protein kinase 1, transcript variant X2
death-associated protein kinase 1 isoform X3
death-associated protein kinase 1 isoform X1
death-associated protein kinase 1 isoform X4
death-associated protein kinase 1 isoform X5
uncharacterized LOC123280274, transcript variant X2
uncharacterized LOC123280274, transcript variant X1
death associated protein kinase 1, transcript variant X6
death-associated protein kinase 1 isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 99% coverage of the annotated genomic feature by RNAseq alignments
aminopeptidase O (putative), transcript variant X14
aminopeptidase O (putative), transcript variant X21
aminopeptidase O (putative), transcript variant X6
aminopeptidase O (putative), transcript variant X17
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 4 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X23
aminopeptidase O (putative), transcript variant X22
aminopeptidase O (putative), transcript variant X19
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 2 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X20
aminopeptidase O (putative), transcript variant X16
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 4 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X15
aminopeptidase O (putative), transcript variant X11
aminopeptidase O (putative), transcript variant X3
aminopeptidase O (putative), transcript variant X12
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 12 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X13
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 9 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X7
aminopeptidase O (putative), transcript variant X9
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 7 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 19 samples with support for all annotated introns
aminopeptidase O (putative), transcript variant X18
aminopeptidase O (putative), transcript variant X8
aminopeptidase O (putative), transcript variant X5
aminopeptidase O (putative), transcript variant X2
aminopeptidase O (putative), transcript variant X4
aminopeptidase O (putative), transcript variant X1
aminopeptidase O (putative), transcript variant X10
aminopeptidase O (putative), transcript variant X24
FA complementation group C, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, 5 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 37 samples with support for all annotated introns
FA complementation group C, transcript variant X1
FA complementation group C, transcript variant X4
FA complementation group C, transcript variant X5
FA complementation group C, transcript variant X2
FA complementation group C, transcript variant X6
COP9 signalosome complex subunit 4-like, transcript variant X1
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 14 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments
COP9 signalosome complex subunit 4-like, transcript variant X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 96% coverage of the annotated genomic feature by RNAseq alignments
COP9 signalosome complex subunit 4-like isoform X1
COP9 signalosome complex subunit 4-like isoform X2
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 90% coverage of the annotated genomic feature by RNAseq alignments, including 11 samples with support for all annotated introns
tigger transposable element-derived protein 1-like
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 mRNA, and 96% coverage of the annotated genomic feature by RNAseq alignments
ERCC excision repair 6 like 2, transcript variant X4
ERCC excision repair 6 like 2, transcript variant X1
ERCC excision repair 6 like 2, transcript variant X6
ERCC excision repair 6 like 2, transcript variant X8
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, 2 Proteins, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 46 samples with support for all annotated introns
ERCC excision repair 6 like 2, transcript variant X9
DNA excision repair protein ERCC-6-like 2 isoform X1
DNA excision repair protein ERCC-6-like 2 isoform X4
DNA excision repair protein ERCC-6-like 2 isoform X6
DNA excision repair protein ERCC-6-like 2 isoform X7
ERCC excision repair 6 like 2, transcript variant X3
ERCC excision repair 6 like 2, transcript variant X2
DNA excision repair protein ERCC-6-like 2 isoform X2
ERCC excision repair 6 like 2, transcript variant X5
DNA excision repair protein ERCC-6-like 2 isoform X3
ERCC excision repair 6 like 2, transcript variant X7
DNA excision repair protein ERCC-6-like 2 isoform X5
hydroxysteroid 17-beta dehydrogenase 3, transcript variant X2
hydroxysteroid 17-beta dehydrogenase 3, transcript variant X1
testosterone 17-beta-dehydrogenase 3 isoform X2
testosterone 17-beta-dehydrogenase 3 isoform X1
solute carrier family 35 member D2, transcript variant X7
solute carrier family 35 member D2, transcript variant X9
solute carrier family 35 member D2, transcript variant X4
solute carrier family 35 member D2, transcript variant X1
solute carrier family 35 member D2, transcript variant X2
solute carrier family 35 member D2, transcript variant X3
solute carrier family 35 member D2, transcript variant X8
solute carrier family 35 member D2, transcript variant X10
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X6
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X4
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X1
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X2
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X7
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X9
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X8
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X3
solute carrier family 35 member D2, transcript variant X5
solute carrier family 35 member D2, transcript variant X6
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 65 samples with support for all annotated introns
UDP-N-acetylglucosamine/UDP-glucose/GDP-mannose transporter isoform X5
zinc finger protein 367, transcript variant X2
zinc finger protein 367, transcript variant X1
hyaluronan binding protein 4, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 100% coverage of the annotated genomic feature by RNAseq alignments, including 35 samples with support for all annotated introns
hyaluronan binding protein 4, transcript variant X2
hyaluronan binding protein 4, transcript variant X1
intracellular hyaluronan-binding protein 4 isoform X1
intracellular hyaluronan-binding protein 4 isoform X2
intracellular hyaluronan-binding protein 4 isoform X3
LOW QUALITY PROTEIN: dual specificity protein phosphatase CDC14B
peroxiredoxin like 2C, transcript variant X2
peroxiredoxin like 2C, transcript variant X1
zinc finger protein 782-like, transcript variant X4
zinc finger protein 782-like, transcript variant X1
zinc finger protein 782-like, transcript variant X2
zinc finger protein 782-like, transcript variant X3
zinc finger protein 782-like, transcript variant X5
zinc finger protein 782-like, transcript variant X6
zinc finger protein 510, transcript variant X1
zinc finger protein 510, transcript variant X7
zinc finger protein 510, transcript variant X4
zinc finger protein 510, transcript variant X6
zinc finger protein 510, transcript variant X3
zinc finger protein 510, transcript variant X2
zinc finger protein 510, transcript variant X5
uncharacterized LOC123280090, transcript variant X2
uncharacterized LOC123280090, transcript variant X1
spermatogenesis-associated protein 31D3-like
uncharacterized LOC106844428, transcript variant X2
uncharacterized LOC106844428, transcript variant X1
uncharacterized LOC123280218, transcript variant X2
uncharacterized LOC123280218, transcript variant X1
uncharacterized LOC106824266, transcript variant X3
uncharacterized LOC106824266, transcript variant X1
uncharacterized LOC106824266, transcript variant X2
heparan sulfate glucosamine 3-O-sulfotransferase 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 7 mRNAs, 2 Proteins, and 98% coverage of the annotated genomic feature by RNAseq alignments, including 3 samples with support for all annotated introns
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 2 bases in 1 codon; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: heparan sulfate glucosamine 3-O-sulfotransferase 4-like
The sequence of the model RefSeq transcript was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 5 codons
The sequence of the model RefSeq protein was modified relative to this genomic sequence to represent the inferred CDS: inserted 8 bases in 5 codons; Derived by automated computational analysis using gene prediction method: Gnomon.
LOW QUALITY PROTEIN: zinc finger protein 658-like
spermatogenesis-associated protein 31A6-like
uncharacterized LOC123280069, transcript variant X2
uncharacterized LOC123280069, transcript variant X1
uncharacterized LOC123280069, transcript variant X3
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 8 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 1 Protein, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 6 samples with support for all annotated introns
zinc finger protein 658, transcript variant X2
zinc finger protein 658, transcript variant X3
zinc finger protein 658, transcript variant X1
zinc finger protein 658, transcript variant X4
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 2 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 7 samples with support for all annotated introns
Derived by automated computational analysis using gene prediction method: Gnomon. Supporting evidence includes similarity to: 3 mRNAs, and 100% coverage of the annotated genomic feature by RNAseq alignments, including 15 samples with support for all annotated introns